These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17951917)
1. Enterobacter endophthalmitis: treatment with intravitreal tazobactam - piperacillin. Singh TH; Pathengay A; Das T; Sharma S Indian J Ophthalmol; 2007; 55(6):482-3. PubMed ID: 17951917 [No Abstract] [Full Text] [Related]
2. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis. Ozkiriş A; Evereklioglu C; Akgün H; Eşel D; Caner F; Erkiliç K Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis. Pathengay A; Mathai A; Shah GY; Ambatipudi S J Cataract Refract Surg; 2010 Dec; 36(12):2210-1. PubMed ID: 21111328 [No Abstract] [Full Text] [Related]
4. The efficacy of piperacillin/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: a histopathological and microbiological evaluation. Ozkiris A; Evereklioglu C; Esel D; Akgün H; Göktas S; Erkiliç K Curr Eye Res; 2005 Jan; 30(1):13-9. PubMed ID: 15875360 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin. Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265 [TBL] [Abstract][Full Text] [Related]
6. An "epidemic" of post cataract surgery endophthalmitis by a new organism. Korah S; Braganza A; Jacob P; Balaji V Indian J Ophthalmol; 2007; 55(6):464-6. PubMed ID: 17951908 [TBL] [Abstract][Full Text] [Related]
7. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis. Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204 [TBL] [Abstract][Full Text] [Related]
8. Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species. Schwaber MJ; Graham CS; Sands BE; Gold HS; Carmeli Y Antimicrob Agents Chemother; 2003 Jun; 47(6):1882-6. PubMed ID: 12760862 [TBL] [Abstract][Full Text] [Related]
9. Dave VP; Pathengay A; Behera S; Joseph J; Sharma S; Pappuru RR; Das T Indian J Ophthalmol; 2020 Jan; 68(1):112-117. PubMed ID: 31856484 [TBL] [Abstract][Full Text] [Related]
10. [Fundamental and clinical studies on beta-lactamase inhibitors]. Niki Y Nihon Rinsho; 2001 Apr; 59(4):771-6. PubMed ID: 11305004 [TBL] [Abstract][Full Text] [Related]
11. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Relhan N; Pathengay A; Schwartz SG; Flynn HW Retina; 2017 May; 37(5):811-818. PubMed ID: 28338559 [No Abstract] [Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam. Kim MK; Capitano B; Mattoes HM; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355 [TBL] [Abstract][Full Text] [Related]
13. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections. Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; Alonso JM; Scavizzi MR Antimicrob Agents Chemother; 1996 Feb; 40(2):325-30. PubMed ID: 8834874 [TBL] [Abstract][Full Text] [Related]
18. Endogenous bacterial endophthalmitis caused by Pantoea species: a case report. Kletke SN; Brissette AR; Gale J Can J Ophthalmol; 2014 Feb; 49(1):e1-2. PubMed ID: 24513369 [No Abstract] [Full Text] [Related]
19. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Peterson LR Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():181-4. PubMed ID: 18154544 [TBL] [Abstract][Full Text] [Related]
20. Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants). Higashitani F; Nishida K; Hyodo A; Inoue M J Antibiot (Tokyo); 1995 Sep; 48(9):1027-33. PubMed ID: 7592048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]